Canada Approves Its First Automated Insulin System for Pregnancy

Pregnancy with type 1 diabetes can mean checking your blood sugar around the clock, adjusting insulin as your body changes week by week, and lying awake worrying about the numbers. For the first time, women in Canada in that situation have a system approved to take over a big share of that work.

Health Canada has cleared the Dexcom G7 glucose monitor for use with myLoop, powered by the CamAPS FX app, which makes it the only automated insulin system in Canada approved specifically for use during pregnancy, mylife Diabetes Care Canada announced on Monday. The Globe and Mail reported that the clearance came on October 30, according to the company. Until then, none of the four automated systems sold in Canada had been approved for pregnancy anywhere in North America.

Key takeaways

Health Canada cleared myLoop with the Dexcom G7 monitor for use in pregnancy on October 30, 2026, according to mylife Diabetes Care.

It is the only automated insulin delivery system in Canada approved specifically for use by pregnant women with type 1 diabetes.

In the AiDAPT trial, pregnant women using the CamAPS FX algorithm spent about two and a half more hours a day in their target range.

The company is targeting late 2026 or early 2027 for the glucose monitor component to become commercially available.

Coverage for pumps and sensors differs by province, so the approval alone does not settle what you will pay.

What does a hybrid closed-loop system actually do?

An automated insulin delivery system links three things: a sensor that reads your glucose every few minutes, an insulin pump, and software that decides how much background insulin to give. In myLoop's case, that software is CamAPS FX, an app on your phone that learns from your readings and adjusts insulin delivery without waiting for you to tap a button.

It is a hybrid closed-loop system, which means the automation covers the background insulin while you still give insulin for meals yourself. The app is authorized for people with type 1 diabetes aged two and older, and myLoop first launched in Canada in March 2025 as the country's first smartphone-based automated system.

Why do insulin needs change so much during pregnancy?

Pregnancy is exactly where this kind of technology gets tested. Insulin needs can shift considerably from one trimester to the next, while the blood sugar targets doctors set for pregnancy stay tighter than at any other time, and that combination is hard to manage by hand.

Alexandra Yeryomin, a Montreal woman living with type 1 diabetes, told The Globe that these devices made a dramatic difference during her pregnancy, a time when both the risks and the stress of the condition are amplified. Her experience matches what many women describe, which is the relief of no longer making every small correction alone. Blood sugar is also only one of several things a pregnancy care team watches, and our report on how pregnancy weight gain affects complication risk covers another.

How much more time in range did women get in the trials?

The research behind the approval is strong. In the AiDAPT trial, a randomized study published in 2023, pregnant women who used CamAPS FX spent about 10.5 percentage points more of each day in their target range. Compared with standard insulin therapy, that works out to roughly two and a half extra hours of time in range a day.

A separate trial with deep Canadian roots points the same way. The CIRCUIT trial, co-led by Dr. Lois Donovan of the University of Calgary, tested a different system at centres in Canada and Australia, and its results helped that system win clearance for pregnancy from the U.S. Food and Drug Administration in April.

When can you actually get the full setup?

There is one practical caveat. The Globe reported that mylife Diabetes Care is targeting late 2026 or early 2027 for one component, the glucose monitor, to become commercially available, so the full setup approved for pregnancy may take a little time to reach you.

Cost is the other question. Health Canada approves medical devices, while provinces and private insurers decide what they will pay for, as our guide to who decides what in Canadian health care explains. British Columbia, for example, added the YpsoPump to PharmaCare coverage as the first automated insulin pump on its list, so it is worth checking what your own plan covers.

How should you plan a pregnancy with your care team?

If you live with type 1 diabetes and are pregnant or hoping to be, the most useful step is a planning conversation with your care team before you conceive. Blood sugar in the earliest weeks matters, and changing insulin systems takes time to get right. If you are not on an automated system yet, a written record of your readings makes that first visit far more useful, and our free printable blood sugar log is built for exactly that.

Start before you conceive. Ask your diabetes clinic for a preconception visit several months before you start trying, and use our guide to preparing for a doctor's appointment to bring your questions in writing.

Ask which systems are approved for pregnancy. Ask whether an automated insulin system makes sense for you and how its settings would change as the weeks go by.

Check your coverage. Ask your provincial program or private insurer what it pays for pumps and sensors, since coverage varies widely.

Keep your current setup until your team says otherwise. If you already use a different system and are pregnant, do not switch devices or change settings on your own.

Use World Diabetes Day as a reminder. November 14 is a good moment to check that your care plan still fits your life.

Frequently asked questions

Can you use an insulin pump while pregnant?

Many women use an insulin pump during pregnancy, and some have used automated systems off-label with their doctor's guidance. What is new in Canada is an automated insulin system formally reviewed and approved for pregnancy. Your diabetes care team can tell you which devices suit your situation and how the settings should change as your pregnancy progresses.

Is it safe to switch insulin systems mid-pregnancy?

Switching systems during pregnancy is possible, though it should happen only with your care team's support, because the first weeks on any new device involve learning and adjustment. Bring the question to your next appointment instead of changing devices or settings on your own, so your team can weigh the timing against your current control.

Do provinces cover insulin pumps and sensors?

Coverage for insulin pumps and glucose sensors differs from province to province, and private insurance plans vary too. Some programs cover pumps for people with type 1 diabetes of any age, while others set limits. Ask your diabetes clinic or pharmacist about your provincial program, and check your workplace benefits before you commit to a device.

Your next step

If you are living with type 1 diabetes and thinking about a pregnancy, the plan starts long before the first ultrasound. The Medimap Health Hub has more on coverage and health care in Canada, and you can find a family doctor near you to start building that plan.

Disclaimer: This article is for general information only and is not medical advice. It does not replace a conversation with a doctor or other qualified health professional who knows your history. If you think you are having a medical emergency, call 911 or go to the nearest emergency department.